Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bickel

Showing results (41-50 of 241) with videos related to

Pageof 25
Sort By:
Gesnerus|January 1, 1996
[75 years Swiss Society of History of Medicine and Natural Sciences]M H Bickel
Drug Metabolism Reviews|January 1, 1989
What can the use of unmetabolizable lipophilic compounds tell about the importance of drug metabolism?M H Bickel
Therapeutische Umschau. Revue Therapeutique|October 1, 1974
[Toxicity of cyclamates and saccharin]M H Bickel
Archives of Biochemistry and Biophysics|January 1, 1972
Liver metabolic reactions: tertiary amine N-dealkylation, tertiary amine N-oxidation, N-oxide reduction, and N-oxide N-dealkylation. I. Tricyclic tertiary amine drugsM H Bickel
Universitas|January 1, 1984
[Not Available]M H Bickel
Gesnerus|July 28, 2001
[History of medicine and pharmacology. Aspects of the history of interdisciplinary relations]M H Bickel
Gesnerus|January 1, 1988
The development of sulfonamides (1932-1938) as a focal point in the history of chemotherapyM H Bickel
Gesnerus. Supplement|October 6, 2000
[The development of experimental pharmacology 1790-1850]M H Bickel
Experientia|August 15, 1982
Polychlorinated persistent compoundsM H Bickel
Gesnerus|August 5, 1999
[The American Malaria Program (1941-1946) and its sequelae for biomedical research after World War II]M H Bickel
Pageof 25

Showing results (41-50 of 241) with videos related to

Sort By:
Pageof 25
Gesnerus|January 1, 1996
[75 years Swiss Society of History of Medicine and Natural Sciences]M H Bickel
Drug Metabolism Reviews|January 1, 1989
What can the use of unmetabolizable lipophilic compounds tell about the importance of drug metabolism?M H Bickel
Therapeutische Umschau. Revue Therapeutique|October 1, 1974
[Toxicity of cyclamates and saccharin]M H Bickel
Archives of Biochemistry and Biophysics|January 1, 1972
Liver metabolic reactions: tertiary amine N-dealkylation, tertiary amine N-oxidation, N-oxide reduction, and N-oxide N-dealkylation. I. Tricyclic tertiary amine drugsM H Bickel
Universitas|January 1, 1984
[Not Available]M H Bickel
Gesnerus|July 28, 2001
[History of medicine and pharmacology. Aspects of the history of interdisciplinary relations]M H Bickel
Gesnerus|January 1, 1988
The development of sulfonamides (1932-1938) as a focal point in the history of chemotherapyM H Bickel
Gesnerus. Supplement|October 6, 2000
[The development of experimental pharmacology 1790-1850]M H Bickel
Experientia|August 15, 1982
Polychlorinated persistent compoundsM H Bickel
Gesnerus|August 5, 1999
[The American Malaria Program (1941-1946) and its sequelae for biomedical research after World War II]M H Bickel
Pageof 25